ImmuneOnco Biopharmaceuticals (Shanghai) (1541.HK) Q3 2024 Earnings

26AugConfirmed
Q3 2024
-0.47
-0.14
0.19
0.53

Details

Expected EPS
N/A
Actual EPS
-0.47191223552
Surprise EPS
-0.47
Surprise Percent
+∞%

Description

ImmuneOnco Biopharmaceuticals (Shanghai) (1541.HK) has reported earnings of -0.47191223552 per share for Q3 2024.

0 Comments

Share your thoughts